Loading...
Loading...
Pharmaceutical Importer Β· #12 buyer for Tramadol Β· $450.0K import value Β· 9 shipments Β· CANADA Β· DGFT Verified
Taro Pharmaceuticals Inc., is the #12 importer of Tramadol from India with $450.0K in import value and 9 verified shipments. Taro Pharmaceuticals Inc., holds a 0.1% market share in Tramadol imports based in CANADA. Overall, Taro Pharmaceuticals Inc., imports 12 pharmaceutical products worth $6.8M across 6 therapeutic categories.

| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| RUBICON RESEARCH PRIVATE LIMITED | $11.4M | 228 | 2 |
| UNICHEM LABORATORIES LIMITED | $10.3M | 217 | 9 |
| MEDREICH LIMITED | $8.2M | 229 | 9 |
| GRACURE PHARMACEUTICALS LIMITED | $5.6M | 124 | 4 |
| ZYDUS LIFESCIENCES LIMITED | $5.5M | 208 | 13 |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | $5.1M | 102 | 4 |
| INDOCO REMEDIES LIMITED | $4.3M | 87 | 7 |
| AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $4.2M | 83 | 1 |
| AUROBINDO PHARMA LTD | $3.6M | 183 | 4 |
| REKVINA PHARMACEUTICALS | $3.3M | 65 | 2 |
India's top Tramadol suppliers include RUBICON RESEARCH PRIVATE LIMITED, UNICHEM LABORATORIES LIMITED, MEDREICH LIMITED. These companies represent the primary source of Tramadol exports from India, serving buyers like Taro Pharmaceuticals Inc., in CANADA and other global markets.
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | DIRECT CUSTOMER SOLUTION | UNITED STATES | $1.1M | 23 | $50.0K |
| 18 | RELON CHEM LTD., | UNITED KINGDOM | $850.0K | 17 | $50.0K |
| 12 | TARO PHARMACEUTICALS INC., β | CANADA | $450.0K | 9 | $50.0K |
Taro Pharmaceuticals Inc., ranks #12 among 789 Tramadol importers from India. Average shipment value of $50.0K compared to the market average of $48.9K. The closest competitors by value are DIRECT CUSTOMER SOLUTION and RELON CHEM LTD.,.
What Taro Pharmaceuticals Inc., and other importers must comply with to import Tramadol from India
Health Canada (HC)
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12β18 months
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
India exported $38.6M worth of Tramadol through 3,928 shipments from 249 suppliers to 103 countries, serving 789 buyers globally. Taro Pharmaceuticals Inc., imports $450.0K of this total, accounting for 0.1% of India's Tramadol exports with 9 shipments from CANADA.
Taro Pharmaceuticals Inc.,'s average Tramadol order value is $50.0K per consignment, based on 9 shipments totaling $450.0K. Taro Pharmaceuticals Inc., is based in CANADA and ranks #12 among all Tramadol importers from India by value.
Top Indian Tramadol suppliers include RUBICON RESEARCH PRIVATE LIMITED ($11.4M), UNICHEM LABORATORIES LIMITED ($10.3M), MEDREICH LIMITED ($8.2M), GRACURE PHARMACEUTICALS LIMITED ($5.6M), ZYDUS LIFESCIENCES LIMITED ($5.5M). These companies represent the primary source of Tramadol exports from India.
Taro Pharmaceuticals Inc., ranks #12 among 789 Tramadol importers from India with a 0.1% market share. The top 3 importers are EVERSANA LIFE SCIENCES SERVICES LLC ($10.1M), SUBSTIPHARM ($6.8M), RXCROSSROADS 3PL LLC ($3.0M). Taro Pharmaceuticals Inc., processed 9 shipments from CANADA.
Taro Pharmaceuticals Inc., imports 12 products worth $6.8M. Beyond Tramadol, top products include Temozolomide, Sunitinib, Budesonide, Dasatinib, Doxorubicin. View the complete Taro Pharmaceuticals Inc., profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Tramadol β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for Taro Pharmaceuticals Inc.,'s Tramadol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Taro Pharmaceuticals Inc.,
Full Company Profile β
12 products Β· $6.8M total trade Β· 6 categories
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 103+ countries, 789+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for Taro Pharmaceuticals Inc.,.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tramadol. For current order-level data, contact TransData Nexus.